Blocking reduces nonspecific binding at the membrane before antibody detection begins. This preserves the distinction between signal produced through recognition of the target by the primary antibody and background interactions that could obscure it. In practice, effective blocking supports clearer interpretation of whether a spot reflects the protein or antigen of interest.
The primary antibody provides target recognition by binding the protein or antigen deposited on the membrane. A labeled secondary antibody then functions in the detection system after primary-antibody recognition and generates the visible or measurable signal. This arrangement translates target presence into an observable spot without requiring the sample’s proteins to be separated first.
Signal presence provides qualitative evidence that the target protein or antigen is present, whereas signal intensity can support a semi-quantitative comparison among samples. In genetics research, those comparisons can indicate differences in protein products associated with genetic variants. The result does not replace full protein separation when detailed separation is required, because the assay is designed for screening.
Researchers apply each biological sample as a discrete spot to a membrane, block nonspecific binding sites, add a primary antibody, and then use a labeled secondary antibody to produce a visible or measurable signal. Comparing the resulting spots provides the readout. This workflow supports parallel handling of many samples while avoiding a protein-separation step.
It places samples in a common membrane-based detection workflow, so researchers can compare whether the target protein is detected and how strongly it appears across variants. The resulting presence or intensity differences provide qualitative or semi-quantitative evidence about protein products associated with those genetic backgrounds. This makes the assay useful for screening expression patterns rather than resolving proteins individually.
A sample containing a suspected recombinant product can be spotted onto the membrane and tested with antibodies directed toward the relevant target. Detection supplies evidence that the protein product is present, while signal strength permits a semi-quantitative comparison across samples. Because many spots can be screened without full protein separation, the method is suited to efficient production checks.